News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,995 Results
Type
Article (39025)
Company Profile (279)
Press Release (645691)
Section
Business (203858)
Career Advice (1996)
Deals (35362)
Drug Delivery (85)
Drug Development (80786)
Employer Resources (168)
FDA (16086)
Job Trends (14802)
News (344526)
Policy (32433)
Tag
Academia (2530)
Alliances (49062)
Alzheimer's disease (1225)
Approvals (16013)
Artificial intelligence (125)
Bankruptcy (352)
Best Places to Work (11528)
Biotechnology (200)
Breast cancer (116)
Cancer (1031)
Cardiovascular disease (86)
Career advice (1662)
Cell therapy (220)
Clinical research (64124)
Collaboration (365)
Compensation (188)
COVID-19 (2528)
C-suite (87)
Data (1041)
Diabetes (150)
Diagnostics (6131)
Earnings (84796)
Employer resources (146)
Events (109342)
Executive appointments (279)
FDA (16591)
Funding (329)
Gene therapy (170)
GLP-1 (572)
Government (4322)
Healthcare (18663)
Infectious disease (2610)
Inflammatory bowel disease (104)
Interviews (312)
IPO (16284)
Job creations (3623)
Job search strategy (1420)
Layoffs (412)
Legal (7851)
Lung cancer (165)
Manufacturing (170)
Medical device (13169)
Medtech (13174)
Mergers & acquisitions (19136)
Metabolic disorders (390)
Neuroscience (1481)
NextGen Class of 2024 (6499)
Non-profit (4463)
Northern California (1413)
Obesity (226)
Opinion (178)
Patents (98)
People (56205)
Phase I (19906)
Phase II (28241)
Phase III (21065)
Pipeline (441)
Postmarket research (2553)
Preclinical (8471)
Radiopharmaceuticals (234)
Rare diseases (206)
Real estate (5889)
Regulatory (21493)
Research institute (2308)
Resumes & cover letters (350)
Southern California (1261)
Startups (3560)
United States (13007)
Vaccines (547)
Weight loss (165)
Date
Last 7 days (919)
Last 30 days (3407)
Last 365 days (35388)
2024 (32087)
2023 (40075)
2022 (51173)
2021 (55714)
2020 (54088)
2019 (46543)
2018 (35019)
2017 (32109)
2016 (31482)
2015 (37554)
2014 (31319)
2013 (26348)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (713)
Arizona (190)
Asia (37089)
Australia (6050)
California (3182)
Canada (1254)
China (237)
Colorado (142)
Connecticut (143)
Europe (79425)
Florida (438)
Georgia (112)
Illinois (336)
Indiana (190)
Kansas (96)
Maryland (567)
Massachusetts (2520)
Michigan (153)
Minnesota (268)
New Jersey (920)
New York (926)
North Carolina (689)
Northern California (1413)
Ohio (133)
Pennsylvania (815)
South America (1091)
Southern California (1261)
Texas (435)
Utah (88)
Washington State (351)
684,995 Results for "macrogenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MacroGenics Announces Leadership Transition
October 30, 2024
·
6 min read
BioCapital
MacroGenics to Participate in Upcoming June 2024 Investor Conference
MacroGenics, Inc., a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, announced that the Company’s management will participate in the following investor conference this month:
June 11, 2024
·
1 min read
BioCapital
MacroGenics to Participate in Upcoming Investor Conferences - May 13, 2024
MacroGenics, Inc. today announced that the Company’s management will participate in the following investor conferences this month.
May 13, 2024
·
1 min read
Press Releases
MacroGenics to Participate in Upcoming November 2024 Investor Conferences
November 7, 2024
·
1 min read
Press Releases
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
October 23, 2024
·
10 min read
Business
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
MacroGenics, Inc. today announced that the Company will release its financial results for the first quarter of 2024 after the market closes on Thursday, May 9, 2024.
May 3, 2024
·
1 min read
Press Releases
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
November 5, 2024
·
13 min read
Press Releases
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
October 29, 2024
·
1 min read
Drug Development
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
MacroGenics, Inc. provided an update on its recent corporate progress and reported financial results for the quarter ended March 31, 2024.
May 9, 2024
·
16 min read
BioCapital
MacroGenics to Participate in Upcoming Investor Conference - February 02, 2024
MacroGenics, Inc. announced that the Company’s management will participate in the following upcoming investor conference.
February 2, 2024
·
1 min read
1 of 68,500
Next
